Business Development

Given the breadth of the portfolio, the Company will pursue a multi-pronged strategy of internal development, primarily focused in the Urology field and partnerships to create additional shareholder value.

Mt Cook will be looking for development and marketing partners to help it take its Clinical stage programs into Phase III and beyond.
In addition, Mt Cook has the most robust library of delta opioid receptor agonists in the pharmaceutical industry; each of the compounds has been tested in vivo and many have been shown to have unique and distinct pharmacologic properties. Several of these compounds are ready to advance to the clinic, but are outside the Company’s current therapeutic focus. The company is actively seeking partners to advance the development of these compounds.

For business development inquiries contact:

Bryan Jones, Ph.D.
Vice President, Business Development
Suite 400, 4370 La Jolla Village Dr.
San Diego, CA 92122
Office: 858-646-3074
Fax: 858-546-9227